Hostname: page-component-586b7cd67f-t7fkt Total loading time: 0 Render date: 2024-11-27T14:29:32.376Z Has data issue: false hasContentIssue false
  • English
  • Français

The Age of Onset of Parkinson's Disease: Etiological Implications

Published online by Cambridge University Press:  18 September 2015

H. Teräväinen ,
L. Forgach ,
M. Hietanen ,
M. Schulzer ,
Bruce Schoenberg  and
D.B. Calne
H. Teräväinen
Affiliation:
Department of Neurology, University of Helsinki, Finland
L. Forgach
Affiliation:
University of British Columbia, Health Sciences Centre Hospital
M. Hietanen
Affiliation:
Department of Neurology, University of Helsinki, Finland
M. Schulzer
Affiliation:
University of British Columbia, Health Sciences Centre Hospital
Bruce Schoenberg
Affiliation:
Neuroepidemiology Branch, NINCDS, Bethesda, Maryland
D.B. Calne*
Affiliation:
University of British Columbia, Health Sciences Centre Hospital
*
The University of British Columbia, Health Sciences Centre Hospital, 2211 Wesbrook Mall, Vancouver, B.C., Canada V6T 1W5
Rights & Permissions [Opens in a new window]

Abstract:

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

We have conducted a hospital-based survey of the age-specific prevalence of Parkinson's disease in 551 patients from Helsinki and Vancouver. We conclude that the disorder may be starting earlier than previously and we discuss the implications of this finding for the etiology of Parkinson's disease.

Type
Original Articles
Information
Canadian Journal of Neurological Sciences , Volume 13 , Issue 4 , November 1986 , pp. 317 - 319
Copyright
Copyright © Canadian Neurological Sciences Federation 1986

References

1.Eldridge, R, Rocca, WA.The clinical syndrome of striatal dopamine deficiency: parkinsonism induced by MPTP. New Engl J Med 1985: 313: 1159–1160.Google ScholarPubMed
2.Brewis, M, Poskanzer, DC, Rolland, C, Miller, H.Neurological disease in an English city. Acta Neurol Scand 1966: 42 (Suppl 24): 1–89.Google Scholar
3.Gudmundsson, KRA.A clinical survey of Parkinsonism in Iceland. Acta Neurol Scand 1967: 43 (Suppl 33): 9–61.CrossRefGoogle ScholarPubMed
4.Marnila, RJ, Rinne, UK.Epidemiology of Parkinson’s disease in Finland. Acta Neurol Scand 1976: 53: 81–102.Google Scholar
5.Kurland, LT, Kurtzke, JF, Goldberg, ID. (Eds.) Epidemiology of neurologic and sense organ disorders. Cambridge. Harvard University Press, 1973.Google Scholar
6.Schoenberg, BS, Anderson, DW.Haerer, AF.Prevalence of Parkinson’s disease in the birachial population of Copiah County. Mississippi. Neurology 1985: 35: 841–845.Google ScholarPubMed
7.Kurtzke, JF.Neuroepidemiology. Ann Neurol 1984: 16: 265–277.CrossRefGoogle ScholarPubMed
8.Kessler, II.Epidemiologic studies of Parkinson’s disease: A hospital based survey. Am J Epidemiol 1972: 95: 308–318.CrossRefGoogle ScholarPubMed
9.Broman, T.Parkinson’s syndrome, prevalence and incidence in Goteborg. Acta Neurol Scand 1966: 42 (Suppl 4): 95–101.Google Scholar
10.Ward, CD.Duvoisin, RC, Ince, SE, Nutt, JD.Eldridge, R.Calne, DB.Parkinson’s disease in 65 pairs of twins and in a set of quadruplets. Neurology (Cleveland) 1983: 33: 815–824.CrossRefGoogle Scholar
11.Quinn, NP, Critchley, P.Marsden, CD.Young onset parkinsonism. Neurology 1986; 36 (Suppl 1): 215.Google Scholar
12.Jenkins, AC.Epidemiology of Parkinson’s disease in Victoria. Med J Austr 1966; 2: 496–502.CrossRefGoogle ScholarPubMed
13.Koller, W, Lang, T.Weiner, W, Jankovic, J.Relationship of aging to Parkinson’s disease. VIIIth Internat Symp Parkinson’s Disease. 1985; p 5l.Google Scholar
14.Kessler, II.Parkinson’s disease in epidemiologic perspective. Adv Neurol 1978; 19: 355–384.Google ScholarPubMed
15.Baumann, RJ, Jameson, HD.McKean, HE.Haack, DG, Weisberg, LM.Cigarette smoking and Parkinson’s disease: I. A comparison of cases with matched neighbours. Neurology 1980: 30: 839–843.CrossRefGoogle Scholar
16.Rajput, AH.Epidemiology of Parkinson’s disease. Can J Neurol Sci 1984: 11: 156–159.CrossRefGoogle ScholarPubMed
17.Davis, GC.Williams, AC, Markey, SP, Ebert, MH, Caine, ED.Reichert, CM, Kopin, IJ.Chronic parkinsonism secondary to intravenous injection of meperidine analogues. Psychiat Res 1979; 1: 249–254.CrossRefGoogle ScholarPubMed
18.Langston, JW, Ballard, P.Tetrud, JW, Irwin, I.Chronic parkinsonism in humans due to a product of meperidine-analog synthesis. Science 1983: 219: 979–980.CrossRefGoogle ScholarPubMed
19.Langston, JW, Ballard, P.Parkinsonism induced by l-methyl-4 -phenyl-1,2,3,6-tetrahydropyridine (MPTP): Implications for treatment and the pathogenesis of Parkinson’s disease. Can J Neurol Sci 1984; 2: 160–165.CrossRefGoogle Scholar
20.Burns, RS, Markey, SP, Phillips, JM, Chiueh, CC.The neurotoxicity of l-Methyl-4-phenyl-l .2,3.6-tetrahydropyridine in the monkey and man. Can J Neurol Sci 1984: 2: 166–168.CrossRefGoogle Scholar
21.Rajput, AH, Stern, W, Christ, A, Laverty, W.Etiology of Parkinson’s disease: Environmental factor(s). Neurology 1984: 34 (Suppl 1): 207.Google Scholar
22.Barbeau, A, Roy, M.Uneven prevalence of Parkinson’s disease in the province of Quebec. Can J Neurol Sci 1985: 12: 169–170.Google Scholar
23.Tanner, CM.Well water drinking and Parkinson’s disease. Vlllth Internat Symp Parkinson’s Disease. 1985: p 11.Google Scholar
24.Tanner, CM, Kinori, T, Goetz, CG.Carvey, PM.Klawans, HL.Clinical course of Parkinson’s disease: Relationship to age of onset. J Neurol 1985: (Suppl 232) p 25.Google Scholar
25.Snyder, SH.D’Amato, RJ.Predicting Parkinson’s disease. Nature 1985: 317: 198–199.CrossRefGoogle ScholarPubMed
26.Kondo, K.Epidemiological clues for the etiology of Parkinson’s disease. In: Hassler, RG.Christ, JF (Eds.) Advances in Neurology New York, Raven Press 1984: pp 345–351.Google ScholarPubMed
27.Li, SC, Schoenberg, BS, Wang, C, Cheng, X, Rui, D, Bolis, CL, Schoenberg, DG.A Prevalence survey of Parkinson’s disease and other movement disorders in the Peoples Republic of China. Arch Neurol 1985: 42: 655–657.CrossRefGoogle Scholar